BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22685753)

  • 1. [Role of nuclear factor-κB in pathogenesis of severe sepsis and septic shock: possible mechanisms of gene therapy targeting inflammatory alert cells].
    Matsuda N
    Masui; 2009 Nov; 58 Suppl():S305-11. PubMed ID: 22685753
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alert cell strategy for severe sepsis].
    Matsuda N
    Masui; 2008 Mar; 57(3):327-40. PubMed ID: 18341001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NF-kappaB activity prevents downregulation of alpha1-adrenergic receptors and circulatory failure during CLP-induced sepsis.
    Schmidt C; Kurt B; Höcherl K; Bucher M
    Shock; 2009 Sep; 32(3):239-46. PubMed ID: 19106815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible interventional therapies in severe sepsis or septic shock.
    Wu CC
    Acta Anaesthesiol Taiwan; 2012 Jun; 50(2):74-7. PubMed ID: 22769862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis and the systemic inflammatory response syndrome.
    Paterson RL; Webster NR
    J R Coll Surg Edinb; 2000 Jun; 45(3):178-82. PubMed ID: 10881485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of histamine H4 receptors contributes to splenic apoptosis in septic mice: counteraction of the antiapoptotic action of nuclear factor-kappaB.
    Matsuda N; Teramae H; Futatsugi M; Takano K; Yamamoto S; Tomita K; Suzuki T; Yokoo H; Koike K; Hattori Y
    J Pharmacol Exp Ther; 2010 Mar; 332(3):730-7. PubMed ID: 20008488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepsis criteria, and selection of patients for immunotherapy.
    Thijs LG
    Prog Clin Biol Res; 1994; 388():407-15. PubMed ID: 7831372
    [No Abstract]   [Full Text] [Related]  

  • 8. Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature.
    Rivers EP; Coba V; Whitmill M
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):128-40. PubMed ID: 18443478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Try hard to improve our understanding of sepsis].
    Sheng ZY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Mar; 15(3):131. PubMed ID: 12831610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of neonatal sepsis and septic shock].
    Wojsyk-Banaszak I; Szczapa J
    Przegl Epidemiol; 2006; 60(1):119-26. PubMed ID: 16758750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nuclear factor-kappaB-dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture-induced circulatory failure.
    Schmidt C; Höcherl K; Kurt B; Bucher M
    Crit Care Med; 2008 Aug; 36(8):2363-72. PubMed ID: 18596633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A campaign worth joining: improving outcome in severe sepsis and septic shock using the Surviving Sepsis Campaign guidelines.
    Patel GP; Elpern EH; Balk RA
    South Med J; 2007 Jun; 100(6):557-8. PubMed ID: 17591307
    [No Abstract]   [Full Text] [Related]  

  • 14. A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock.
    Wheatley C
    Med Hypotheses; 2006; 67(1):124-42. PubMed ID: 16545917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing, treating and managing patients with sepsis.
    Robson W; Newell J
    Nurs Stand; 2005 Aug 24-30; 19(50):56-64. PubMed ID: 16138619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma exchange in severe sepsis or septic shock.
    Kes P
    Acta Med Croatica; 1998; 52(2):127-32. PubMed ID: 9682501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated nucleosome levels in systemic inflammation and sepsis.
    Zeerleder S; Zwart B; Wuillemin WA; Aarden LA; Groeneveld AB; Caliezi C; van Nieuwenhuijze AE; van Mierlo GJ; Eerenberg AJ; Lämmle B; Hack CE
    Crit Care Med; 2003 Jul; 31(7):1947-51. PubMed ID: 12847387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early identification and treatment of cardiovascular failure in severe sepsis].
    Haase N; White J; Perner A
    Ugeskr Laeger; 2010 Jan; 172(3):210-4. PubMed ID: 20089213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Septicemia without sepsis: inherited disorders of nuclear factor-kappa B-mediated inflammation.
    von Bernuth H; Puel A; Ku CL; Yang K; Bustamante J; Chang HH; Picard C; Casanova JL
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S436-9. PubMed ID: 16237643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis.
    Matsuda N; Hattori Y; Jesmin S; Gando S
    Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.